Tanzanija - engleski - Tanzania Medicinces & Medical Devices Authority

faes farma. s.a, spain - deflazacort - oral tablet - 6

Tanzanija - engleski - Tanzania Medicinces & Medical Devices Authority

faes farma. s.a, spain - deflazacort - tablets - 30

Armenija - engleski - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

faes farma - hidrosmin - capsules - 200mg

Armenija - engleski - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

faes farma s.a. - paracetamol, methocarbamol - tablets - 300mg+ 380mg

Armenija - engleski - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

faes farma s.a. - hidrosmin - capsules - 200mg

Europska Unija - engleski - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - umeclidinium bromide, vilanterol - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - laventair ellipta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Europska Unija - engleski - EMA (European Medicines Agency)

glaxosmithkline trading services limited - umeclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - rolufta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).,

Europska Unija - engleski - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - fluticasone furoate, vilanterol trifenatate - asthma - adrenergics and other drugs for obstructive airway diseases - asthma indicationrevinty ellipta is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older, where use of a combination product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting beta2-agonists.copd indicationrevinty ellipta is indicated for the symptomatic treatment of adults with copd with a fev1

Europska Unija - engleski - EMA (European Medicines Agency)

glaxosmithkline trading services limited - fluticasone furoate, umeclidinium bromide, vilanterol trifenatate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - elebrato ellipta is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist.